Article

Do Opioid Prescribing Guidelines Use Pseudoscience?

Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP, discusses how opioid prescribing guidelines use pseudoscience.

Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP, discusses how opioid prescribing guidelines use pseudoscience.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit: kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
semaglutide is a hormone that is used as a medication for improve blood sugar - Image credit: Fernanda | stock.adobe.com
July 8th 2025

Study Assesses Weight Reduction and Glycemic Status With GLP-1 Medications

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Redefining Pharmacovigilance Through Digital Innovation
July 8th 2025

Redefining Pharmacovigilance Through Digital Innovation

Aabha Daryapurkar, PharmD
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Stethoscope surrounded by crowd figurines | Image Credit: © Eti - stock.adobe.com
July 7th 2025

How Cuts to Federal Health Agencies Fuel Chronic and Infectious Disease Crises

Alexandra Gerlach, Associate Editor
Hepatocellular Carcinoma Cells: These liver cells, or hepatocytes, can develop into tumors in the liver, often associated with cirrhosis or chronic liver disease - Image credit: Best | stock.adobe.com
July 7th 2025

FDA Approves Y-90 Resin Microspheres for Unrespectable Hepatocellular Carcinoma

Kennedy Ferruggia, Assistant Editor